- Docket No.
- 1:21-cv-00691
- District Court
- Delaware
Goal
- Block pharmaceutical company from infringing patent
- Recover damages
Issues
Litigation Content
Why this Matters:
The plaintiffs argue that defendants improperly listed certain patents in the Orange Book to maintain exclusivity and block other generics from entering the market in violation of federal patent and antitrust law. Patent abuses can distort the market for prescription drugs and drive up prices for consumers.
Potential Impact:
Improper patent listings in the Orange Book can undermine fair competition and prohibit or delay consumers from accessing lower-cost generic drugs.
106 Major Filings
- JAZZ’S RESPONSIVE LETTER BRIEF IN SUPPORT OF ONGOING ROYALTY (Oct 4, 2024)
- AMENDED NOTICE OF APPEAL (Sep 27, 2024)
- MEMORANDUM OPINION (Sep 24, 2024)
- PLAINTIFFS’ OPPOSITION TO DEFENDANT’S EMERGENCY MOTION FOR STAY PENDING APPEAL (Sep 17, 2024)
- DEFENDANT’S OPENING BRIEF IN SUPPORT OF EMERGENCY MOTION FOR STAY PENDING APPEAL (Sep 17, 2024)
- DEFENDANT’S EMERGENCY MOTION FOR STAY PENDING APPEAL (Sep 17, 2024)
- ORDER (Sep 10, 2024)
- MEMORANDUM OPINION (Sep 6, 2024)
- NOTICE OF APPEAL (Aug 28, 2024)
- MEMORANDUM OPINION (Jun 13, 2024)
- PLAINTIFFS’ REPLY BRIEF IN SUPPORT OF MOTION FOR A PERMANENT INJUNCTION AND FOR AN ONGOING ROYALTY (May 28, 2024)
- DEFENDANT’S ANSWERING BRIEF IN OPPOSITION TO JAZZ’S MOTION FOR AN INJUNCTION OR ONGOING ROYALTY (May 22, 2024)
- OFFICIAL TRANSCRIPT OF JURY TRIAL (PART 4) (May 1, 2024)
- OFFICIAL TRANSCRIPT OF JURY TRIAL (PART 3) (May 1, 2024)
- OFFICIAL TRANSCRIPT OF JURY TRIAL (PART 2) (May 1, 2024)
- OFFICIAL TRANSCRIPT OF JURY TRIAL (PART 1) (May 1, 2024)
- PLAINTIFFS’ OPENING BRIEF IN SUPPORT OF MOTION FOR A PERMANENT INJUNCTION AND FOR AN ONGOING ROYALTY (Apr 22, 2024)
- MOTION for Permanent Injunction and for an Ongoing Royalty (Apr 22, 2024)
- JOINT POST-TRIAL STATUS REPORT (Mar 13, 2024)
- VERDICT FORM (Mar 5, 2024)
- FINAL JURY INSTRUCTIONS (Mar 1, 2024)
- MEMORANDUM OPINION (Mar 1, 2024)
- STIPULATION OF INFRINGEMENT REGARDING CLAIM 24 OF U.S. PATENT NO. 11,147,782 (Feb 23, 2024)
- PRELIMINARY JURY INSTRUCTIONS (Feb 23, 2024)
- DEFENDANT'S REPLY IN SUPPORT OF SJ AND DAUBERT MOTIONS (Jan 10, 2024)
- REPLY BRIEF IN SUPPORT OF PARTIAL SJ MOTION NO 4 (Jan 10, 2024)
- REPLY BRIEF IN SUPPORT OF PARTIAL SJ MOTION NO 2 (Jan 10, 2024)
- REPLY BRIEF IN SUPPORT OF PARTIAL SJ MOTION NO 3 (Jan 10, 2024)
- REPLY BRIEF IN SUPPORT OF PARTIAL SJ MOTION NO 1 (Jan 10, 2024)
- OPPOSITION TO PLAINTIFFS MOTION FOR SUMMARY JUDGMENT NO. 3 (Jan 10, 2024)
- OPPOSITION TO PLAINTIFFS MOTION FOR SUMMARY JUDGMENT NO. 2 (Jan 10, 2024)
- OPPOSITION TO PLAINTIFFS MOTION FOR SUMMARY JUDGMENT NO. 1 (Jan 10, 2024)
- DEFENDANT’S OPPOSITION TO PLAINTIFFS SUMMARY JUDGMENT (Jan 10, 2024)
- NOTICE OF WITHDRAWAL OF AVADEL’S MOTION FOR SUMMARY JUDGMENT NO. 3 REGARDING NON-INFRINGEMENT (Dec 22, 2023)
- DEFENDANT’S CONCISE STATEMENT OF FACTS IN SUPPORT OF ITS MOTION FOR SUMMARY JUDGMENT NO. 3 (Dec 19, 2023)
- DEFENDANT’S CONCISE STATEMENT OF FACTS IN SUPPORT OF ITS MOTION FOR SUMMARY JUDGMENT NO. 2 (Dec 19, 2023)
- DEFENDANT’S CONCISE STATEMENT OF FACTS IN SUPPORT OF ITS MOTION FOR SUMMARY JUDGMENT NO. 1 (Dec 19, 2023)
- BRIEF IN SUPPORT OF DEFENDANT’S SUMMARY JUDGMENT AND DAUBERT MOTIONS (Dec 19, 2023)
- OPENING BRIEF IN SUPPORT OF PARTIAL SJ NO 4 (Dec 19, 2023)
- OPENING BRIEF IN SUPPORT OF PARTIAL SJ NO 3 (Dec 19, 2023)
- OPENING BRIEF IN SUPPORT OF PARTIAL SJ NO 2 (Dec 19, 2023)
- OPENING BRIEF IN SUPPORT OF PARTIAL SJ NO 1 (Dec 19, 2023)
- AVADEL CNS PHARMACEUTICALS, LLC’S MOTIONS FOR SUMMARY JUDGMENT AND TO EXCLUDE EXPERT TESTIMONY (Nov 30, 2023)
- PLAINTIFFS’ MOTION FOR PARTIAL SUMMARY JUDGMENT NO. 3 OF NONOBVIOUSNESS OF THE SUSTAINED RELEASE PATENTS (Nov 30, 2023)
- PLAINTIFFS’ MOTION FOR PARTIAL SUMMARY JUDGMENT NO. 2 OF NONOBVIOUSNESS OF U.S. PATENT NOS. 11,077,079 AND 11,147,782 (Nov 30, 2023)
- PLAINTIFFS’ MOTION FOR PARTIAL SUMMARY JUDGMENT NO. 1 OF INFRINGEMENT OF THE SUSTAINED RELEASE PATENTS (Nov 30, 2023)
- PLAINTIFFS’ MOTION FOR PARTIAL SUMMARY JUDGMENT NO. 4 OF NO ANTICIPATION OF U.S. PATENT NO. 11,077,079 (Nov 30, 2023)
- JOINT SUPPLEMENTAL CLAIM CONSTRUCTION APPENDIX (Oct 23, 2023)
- JOINT SECOND SUPPLEMENTAL CLAIM CONSTRUCTION BRIEF (Oct 23, 2023)
- 07/31/2023 (Jul 31, 2023)
- ANSWER TO AMENDED COMPLAINT FOR PATENT INFRINGEMENT, DEFENSES AND COUNTERCLAIMS (Jul 10, 2023)
- AMENDED COMPLAINT FOR PATENT INFRINGEMENT (Jun 9, 2023)
- JOINT SUPPLEMENTAL CLAIM CONSTRUCTION APPENDIX (May 4, 2023)
- JOINT SUPPLEMENTAL CLAIM CONSTRUCTION APPENDIX (May 4, 2023)
- JOINT SUPPLEMENTAL CLAIM CONSTRUCTION BRIEF (May 4, 2023)
- MANDATE of USCA (Apr 3, 2023)
- ORDER (Mar 7, 2023)
- STIPULATION AND [PROPOSED] ORDER DISMISSING JAZZ’S ’963 PATENT INFRINGEMENT CLAIM AGAINST AVADEL AND AVADEL’S NONINFRINGEMENT & INVALIDITY COUNTERCLAIMS AGAINST THE ’963 PATENT (Mar 6, 2023)
- MEMORANDUM ORDER (Dec 19, 2022)
- ORDER of USCA (Dec 14, 2022)
- JAZZ PHARMACEUTICALS, INC.’S REPLY BRIEF IN SUPPORT OF ITS MOTION FOR A STAY PENDING APPEAL OR, IN THE ALTERNATIVE, A STAY PENDING APPLICATION TO THE FEDERAL CIRCUIT FOR A STAY PENDING APPEAL (Dec 6, 2022)
- MEMORANDUM ORDER (Dec 5, 2022)
- LETTER TO THE HONORABLE GREGORY B. WILLIAMS FROM DANIEL M. SILVER, ESQ. REGARDING JAZZ'S REPLY BRIEF IN SUPPORT OF ITS MOTION TO STAY (Dec 2, 2022)
- ORDER of USCA (Nov 29, 2022)
- DECLARATION OF JENNIFER GUDEMAN (Nov 29, 2022)
- DECLARATION OF CATHERINE COOK (Nov 29, 2022)
- AVADEL’S BRIEF IN OPPOSITION TO PLAINTIFF’S MOTION FOR A STAY PENDING APPEAL (Nov 29, 2022)
- LETTER TO THE HONORABLE GREGORY B. WILLIAMS FROM DANIEL M. SILVER REGARDING COURT OF APPEALS TO THE FEDERAL CIRCUIT ORDER (Nov 29, 2022)
- JAZZ PHARMACEUTICALS, INC.’S MOTION FOR A STAY PENDING APPEAL OR, IN THE ALTERNATIVE, A STAY PENDING APPLICATION TO THE FEDERAL CIRCUIT FOR A STAY PENDING APPEAL (Nov 22, 2022)
- NOTICE OF APPEAL (Nov 22, 2022)
- ORDER AND JUDGMENT (Nov 18, 2022)
- MEMORANDUM OPINION (Nov 18, 2022)
- ORDER (Nov 18, 2022)
- MEMORANDUM OPINION (Nov 18, 2022)
- FEDERAL TRADE COMMISSION’S BRIEF AS AMICUS CURIAE (Nov 15, 2022)
- DEFENDANT AVADEL CNS PHARMACEUTICALS, LLC’S REPLY IN SUPPORT OF ITS MOTION TO EXPEDITE CONSIDERATION OF ITS RENEWED MOTION FOR PARTIAL JUDGMENT ON THE PLEADING (Sep 20, 2022)
- JAZZ’S RESPONSE TO AVADEL’S MOTION TO EXPEDITE CONSIDERATION OF ITS RENEWED MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Sep 20, 2022)
- ORAL ORDER (Sep 19, 2022)
- PLAINTIFF’S SUR-REPLY IN OPPOSITION TO DEFENDANT’S RENEWED MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Sep 19, 2022)
- DEFENDANT AVADEL CNS PHARMACEUTICALS, LLC’S MOTION TO EXPEDITE CONSIDERATION OF ITS RENEWED MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Sep 13, 2022)
- PLAINTIFF’S ANSWERING BRIEF IN OPPOSITION TO DEFENDANT’S RENEWED MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Sep 2, 2022)
- RESPONSE TO PLAINTIFF’S MOTION FOR LEAVE TO FILE SUR-REPLY (Aug 30, 2022)
- JAZZ’S MOTION FOR LEAVE TO FILE SUR-REPLY (Aug 30, 2022)
- REPLY BRIEF IN SUPPORT OF DEFENDANT’S RENEWED MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Aug 28, 2022)
- ORAL ORDER (Aug 24, 2022)
- AMENDED JOINT CLAIM CONSTRUCTION CHART (Aug 19, 2022)
- ORAL ORDER (Aug 1, 2022)
- JOINT CLAIM CONSTRUCTION APPENDIX (Jul 29, 2022)
- JOINT CLAIM CONSTRUCTION BRIEF (Jul 29, 2022)
- REPLY BRIEF IN SUPPORT OF DEFENDANT’S RENEWED MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Jul 14, 2022)
- PLAINTIFFS’ OBJECTION TO DEFENDANT’S RENEWED MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Jul 7, 2022)
- OPENING BRIEF IN SUPPORT OF DEFENDANT’S RENEWED MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Jun 23, 2022)
- DEFENDANT’S RENEWED MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Jun 23, 2022)
- JOINT CLAIM CONSTRUCTION CHART (May 13, 2022)
- TRANSCRIPT (Apr 29, 2022)
- JAZZ PHARMACEUTICALS, INC.’S FIRST AMENDED ANSWER TO AVADEL CNS PHARMACEUTICALS LLC’S COUNTERCLAIMS (Feb 25, 2022)
- STIPULATION AND ORDER TO AMEND ANSWERS (Feb 24, 2022)
- STIPULATION AND [PROPOSED] ORDER OF DISMISSAL OF COMPLAINT AS TO CERTAIN DEFENDANTS AND TO AMEND CASE CAPTIONS (Jan 4, 2022)
- ORDER (Oct 19, 2021)
- MEMORANDUM OPINION (Oct 19, 2021)
- REPLY BRIEF IN SUPPORT OF AVADEL’S MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Sep 3, 2021)
- PLAINTIFF’S ANSWERING BRIEF IN OPPOSITION TO DEFENDANTS’ MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Aug 20, 2021)
- DEFENDANTS’ MOTION FOR PARTIAL JUDGMENT ON THE PLEADINGS (Jul 23, 2021)
- JAZZ PHARMACEUTICALS, INC.’S ANSWER TO AVADEL CNS PHARMACEUTICALS LLC’S COUNTERCLAIMS (Jun 18, 2021)
- ANSWER TO COMPLAINT FOR PATENT INFRINGEMENT, DEFENSES AND COUNTERCLAIMS (Jun 3, 2021)
- COMPLAINT FOR PATENT INFRINGEMENT (May 12, 2021)